Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Peter J. Zimetbaum, M.D.

TitleAssociate Professor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Medical Center
Cardiovascular Division
185 Pilgrim Road
Boston MA 02215
Phone617/632-9209
Fax617/632-7620

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Kramer DB, Zimetbaum PJ. Ectopy and expectations: can we predict atrial fibrillation, and should we try? Ann Intern Med. 2013 Dec 3; 159(11):787-8.
    View in: PubMed
  2. Waks JW, Zimetbaum PJ. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. Expert Rev Cardiovasc Ther. 2013 Nov; 11(11):1461-71.
    View in: PubMed
  3. Kumar K, Zimetbaum PJ. Antiarrhythmic drugs 2013: state of the art. Curr Cardiol Rep. 2013 Oct; 15(10):410.
    View in: PubMed
  4. Zimetbaum P, Ellis ER, Waks JW, Passman RS. The importance of atrial fibrillation burden and the origin of device-tailored anticoagulation. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1319-24.
    View in: PubMed
  5. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul 1; 6(4):488-97.
    View in: PubMed
  6. Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013 Aug 15; 112(4):520-4.
    View in: PubMed
  7. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23; 62(4):300-5.
    View in: PubMed
  8. Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R. Volumetric Left Ventricular Ejection Fraction is Superior to 2-Dimensional Echocardiography for Risk Stratification of Patients for Primary Prevention Implantable Cardioverter-Defibrillator Implantation. Am J Cardiol. 2013 Apr 15; 111(8):1175-9.
    View in: PubMed
  9. Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013 Mar; 36(3):328-33.
    View in: PubMed
  10. Rosenberg MA, Patton KK, Sotoodehnia N, Karas MG, Kizer JR, Zimetbaum PJ, Chang JD, Siscovick D, Gottdiener JS, Kronmal RA, Heckbert SR, Mukamal KJ. The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J. 2012 Nov; 33(21):2709-17.
    View in: PubMed
  11. Stead W, O'Halloran TD, Bernier M, Zimetbaum PJ, Irish J. Using interprofessional education strategies to improve collaborative attitudes among infectious diseases and cardiology physician trainees. Med Teach. 2012; 34(7):594-5.
    View in: PubMed
  12. Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change--a new approach to ICD replacement. N Engl J Med. 2012 Jan 26; 366(4):291-3.
    View in: PubMed
  13. Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation. 2012 Jan 17; 125(2):381-9.
    View in: PubMed
  14. Reynolds MR, Zimetbaum P. Magnetic resonance imaging and cardiac devices: how safe is safe enough? Ann Intern Med. 2011 Oct 4; 155(7):470-2.
    View in: PubMed
  15. Zimetbaum P. Ask the doctor. I had a pacemaker implanted a few months ago. I am planning to join a gym to get back some strength in my arms and upper body, but I am afraid of damaging the wires with some of the presses and pull down movements I would have to do to work out on the gym's machines. Are there any exercises or movements I should avoid? Harv Heart Lett. 2011 Oct; 22(2):7.
    View in: PubMed
  16. Hsing JM, Selzman KA, Leclercq C, Pires LA, McLaughlin MG, McRae SE, Peterson BJ, Zimetbaum PJ. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy. Circ Arrhythm Electrophysiol. 2011 Dec; 4(6):851-7.
    View in: PubMed
  17. Kramer DB, Zimetbaum PJ. Long-QT syndrome. Cardiol Rev. 2011 Sep-Oct; 19(5):217-25.
    View in: PubMed
  18. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol. 2011 Jun; 57(6):625-9.
    View in: PubMed
  19. Cocchi MN, Miller J, Hunziker S, Carney E, Salciccioli J, Farris S, Joyce N, Zimetbaum P, Howell MD, Donnino MW. The association of lactate and vasopressor need for mortality prediction in survivors of cardiac arrest. Minerva Anestesiol. 2011 Nov; 77(11):1063-71.
    View in: PubMed
  20. Zimetbaum P. Ask the doctor. The "Heart Letter" has said that alcohol can cause heart rhythm problems. I have an implanted defibrillator. Is it okay or me to drink alcohol? Harv Heart Lett. 2011 May; 21(9):8.
    View in: PubMed
  21. Grossman SA, Bar J, Fischer C, Lipsitz LA, Mottley L, Sands K, Zimetbaum P, Shapiro NI. Reducing admissions utilizing the Boston Syncope Criteria. J Emerg Med. 2012 Mar; 42(3):345-52.
    View in: PubMed
  22. Konstantino Y, Morello A, Zimetbaum PJ, Josephson ME. Self-terminated ventricular fibrillation and recurrent syncope. Am J Cardiol. 2011 Feb 15; 107(4):638-40.
    View in: PubMed
  23. Zimetbaum P. Ask the doctor. I recently had a pacemaker implanted. While the process was going on, I felt a pulsation that I reported to the doctor. I still feel it seven months later. Other symptoms include low blood pressure, an increase in weight, and digestive changes. My primary care doctor thinks that my vagus nerve could have been damaged when the pacemaker was implanted. Is that possible? Harv Heart Lett. 2011 Feb; 21(6):8.
    View in: PubMed
  24. Zimetbaum P. In the clinic. Atrial fibrillation. Ann Intern Med. 2010 Dec 7; 153(11):ITC61-15, quiz ITC616.
    View in: PubMed
  25. Martin-Doyle W, Essebag V, Zimetbaum P, Reynolds MR. Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials. J Cardiovasc Electrophysiol. 2011 May; 22(5):548-53.
    View in: PubMed
  26. Zimetbaum P. Ask the doctor. I am an 84-year-old man with atrial fibrillation, mild heart failure, and well-controlled high blood pressure. My doctor had me wear a Holter monitor and get a SPECT scan (which showed mild nonischemic cardiomyopathy). Now he wants me to have a cardiac MRI. What information would this test give that he doesn't already have? Harv Heart Lett. 2010 Nov; 21(3):7.
    View in: PubMed
  27. Zimetbaum P, Goldman A. Ambulatory arrhythmia monitoring: choosing the right device. Circulation. 2010 Oct 19; 122(16):1629-36.
    View in: PubMed
  28. Reynolds MR, Morais E, Zimetbaum P. Impact of hospitalization on health-related quality of life in atrial fibrillation patients in Canada and the United States: results from an observational registry. Am Heart J. 2010 Oct; 160(4):752-8.
    View in: PubMed
  29. Shvilkin A, Bojovic B, Vajdic B, Gussak I, Ho KK, Zimetbaum P, Josephson ME. Vectorcardiographic and electrocardiographic criteria to distinguish new and old left bundle branch block. Heart Rhythm. 2010 Aug; 7(8):1085-92.
    View in: PubMed
  30. Konstantino Y, Zimetbaum PJ, Hsing J, Kramer DB, Chang JD. Cardiac resynchronization therapy for low-flow, low-gradient aortic stenosis. Eur J Heart Fail. 2010 Aug; 12(8):889-92.
    View in: PubMed
  31. Cocchi MN, Lucas JM, Salciccioli J, Carney E, Herman S, Zimetbaum P, Donnino MW. The role of cranial computed tomography in the immediate post-cardiac arrest period. Intern Emerg Med. 2010 Dec; 5(6):533-8.
    View in: PubMed
  32. Zimetbaum PJ, Thosani A, Yu HT, Xiong Y, Lin J, Kothawala P, Emons M. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med. 2010 May; 123(5):446-53.
    View in: PubMed
  33. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2010 Apr 6; 55(14):1416-24.
    View in: PubMed
  34. Stamou SC, Khabbaz KR, Mahmood F, Zimetbaum P, Hagberg RC. A multidisciplinary approach to the minimally invasive pulmonary vein isolation for treatment of atrial fibrillation. Ann Thorac Surg. 2010 Feb; 89(2):648-50.
    View in: PubMed
  35. Han Y, Chan J, Haber I, Peters DC, Zimetbaum PJ, Manning WJ, Yeon SB. Circumferential myocardial strain in cardiomyopathy with and without left bundle branch block. J Cardiovasc Magn Reson. 2010; 12:2.
    View in: PubMed
  36. Zimetbaum P. Ask the doctor. If you have a slow heart rate (bradycardia), is it safe to drink wine? If so, how much per day? Does alcohol affect the heart rate? Harv Heart Lett. 2010 Jan; 20(5):8.
    View in: PubMed
  37. Higashida RT, Popma JJ, Apruzzese P, Zimetbaum P. Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials. Stroke. 2010 Feb; 41(2):e102-9.
    View in: PubMed
  38. Grossman SA, Fischer C, Kancharla A, Lipsitz LA, Mottley L, Zimetbaum P, Shapiro NI. Can benign etiologies predict benign outcomes in high-risk syncope patients? J Emerg Med. 2011 May; 40(5):592-7.
    View in: PubMed
  39. Kumar K, Zimetbaum PJ. New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future. Curr Treat Options Cardiovasc Med. 2009 Oct; 11(5):373-80.
    View in: PubMed
  40. van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, Zimetbaum PJ, Gerritse B, Kristiansen N, Ghio S. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009 Oct; 30(20):2470-7.
    View in: PubMed
  41. Frisch DR, Giedrimas E, Mohanavelu S, Shui A, Ho KK, Gibson CM, Josephson ME, Zimetbaum PJ. Predicting irreversible left ventricular dysfunction after acute myocardial infarction. Am J Cardiol. 2009 May 1; 103(9):1206-9.
    View in: PubMed
  42. Zimetbaum PJ. Dronedarone for atrial fibrillation--an odyssey. N Engl J Med. 2009 Apr 30; 360(18):1811-3.
    View in: PubMed
  43. Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009 Aug; 2(4):362-9.
    View in: PubMed
  44. Shvilkin A, Bojovic B, Vajdic B, Gussak I, Zimetbaum P, Josephson ME. Vectorcardiographic determinants of cardiac memory during normal ventricular activation and continuous ventricular pacing. Heart Rhythm. 2009 Jul; 6(7):943-8.
    View in: PubMed
  45. Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, Morganroth J. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008 Nov; 87(6):319-28.
    View in: PubMed
  46. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008 Sep 30; 52(14):1111-21.
    View in: PubMed
  47. Frisch DR, Haim M, Zimetbaum PJ, Josephson ME. 'Multiblock': what is the mechanism? Heart Rhythm. 2009 Jun; 6(6):860-2.
    View in: PubMed
  48. Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun; 1(3):248-57.
    View in: PubMed
  49. Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, Kissinger KV, Zimetbaum PJ, Manning WJ, Yeon SB. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008 May; 1(3):294-303.
    View in: PubMed
  50. Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol. 2008 Jul; 19(7):762-8.
    View in: PubMed
  51. Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008 Feb 5; 51(5):546-51.
    View in: PubMed
  52. Nezafat R, Han Y, Peters DC, Herzka DA, Wylie JV, Goddu B, Kissinger KK, Yeon SB, Zimetbaum PJ, Manning WJ. Coronary magnetic resonance vein imaging: imaging contrast, sequence, and timing. Magn Reson Med. 2007 Dec; 58(6):1196-206.
    View in: PubMed
  53. Wylie JV, Zimetbaum P, Josephson ME, Shvilkin A. Cardiac memory induced by QRS widening due to propafenone toxicity. Pacing Clin Electrophysiol. 2007 Sep; 30(9):1161-4.
    View in: PubMed
  54. Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, Josephson ME, Zimetbaum P. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27; 167(15):1648-53.
    View in: PubMed
  55. Grossman SA, Fischer C, Lipsitz LA, Mottley L, Sands K, Thompson S, Zimetbaum P, Shapiro NI. Predicting adverse outcomes in syncope. J Emerg Med. 2007 Oct; 33(3):233-9.
    View in: PubMed
  56. Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007 Sep 1; 100(5):818-23.
    View in: PubMed
  57. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007 Jul; 28(14):1709-16.
    View in: PubMed
  58. Zimetbaum PJ. A 59-year-old man considering implantation of a cardiac defibrillator. JAMA. 2007 May 2; 297(17):1909-16.
    View in: PubMed
  59. Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol. 2007 Jun; 18(6):628-33.
    View in: PubMed
  60. Grossman SA, Fischer C, Bar JL, Lipsitz LA, Mottley L, Sands K, Thompson S, Zimetbaum P, Shapiro NI. The yield of head CT in syncope: a pilot study. Intern Emerg Med. 2007 Mar; 2(1):46-9.
    View in: PubMed
  61. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med. 2007 Mar 1; 356(9):935-41.
    View in: PubMed
  62. Essebag V, Wylie JV, Reynolds MR, Baldessin F, McClennen S, Shvilkin A, Germano J, Richardson A, Zimetbaum PJ, Josephson ME. Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol. 2006 Nov; 17(2):111-7.
    View in: PubMed
  63. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, Haines DE, Hayes DL, Heidenreich PA, Miller JM, Poppas A, Prystowsky EN, Schoenfeld MH, Zimetbaum PJ, Heidenreich PA, Goff DC, Grover FL, Malenka DJ, Peterson ED, Radford MJ, Redberg RF. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). J Am Coll Cardiol. 2006 Dec 5; 48(11):2360-96.
    View in: PubMed
  64. Reynolds MR, Lavelle T, Essebag V, Cohen DJ, Zimetbaum P. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart J. 2006 Dec; 152(6):1097-103.
    View in: PubMed
  65. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation. 2006 Dec 5; 114(23):2534-70.
    View in: PubMed
  66. Wylie JV, Milliez P, Germano JJ, Richardson A, Ngwu O, Zimetbaum PJ, Papageorgiou P, Josephson ME. Atrioventricular nodal reentrant tachycardia associated with idiopathic ventricular tachycardia: clinical and electrophysiologic characteristics. J Electrocardiol. 2007 Jan; 40(1):94-9.
    View in: PubMed
  67. Frisch DR, Zimetbaum PJ, Josephson ME. Alternating left bundle branch block and right bundle branch block during tachycardia: what is the mechanism? Heart Rhythm. 2007 May; 4(5):679-80.
    View in: PubMed
  68. McLaughlin MG, Zimetbaum PJ. Electrocardiographic predictors of arrhythmic death. Ann Noninvasive Electrocardiol. 2006 Oct; 11(4):327-37.
    View in: PubMed
  69. Piazza G, Carrozza JP, Zimetbaum PJ. An unusual explanation for episodic dyspnea. Circulation. 2006 Sep 12; 114(11):e485-6.
    View in: PubMed
  70. Zimetbaum P. Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials. Curr Cardiol Rep. 2006 Sep; 8(5):377-86.
    View in: PubMed
  71. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006 Sep-Oct; 9(5):348-56.
    View in: PubMed
  72. Frisch DR, Kwaku KF, Allocco DJ, Zimetbaum PJ. Atrioventricular nodal reentrant tachycardia in two siblings with Wolfram syndrome. J Cardiovasc Electrophysiol. 2006 Sep; 17(9):1029-31.
    View in: PubMed
  73. Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O'Neill WW, Lansky AJ, Griffin JJ. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2006 Aug 1; 98(3):331-7.
    View in: PubMed
  74. Kandzari DE, Tcheng JE, Gersh BJ, Cox DA, Stuckey T, Turco M, Mehran R, Garcia E, Zimetbaum P, McGlaughlin MG, Lansky AJ, Costantini CO, Grines CL, Stone GW. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. Am Heart J. 2006 Jun; 151(6):1288-95.
    View in: PubMed
  75. Wykrzykowska JJ, Kwaku K, Wylie J, Manning WJ, Josephson ME, Zimetbaum P, Laham RJ. Delayed occurrence of unheralded phase IV complete heart block after ethanol septal ablation for symmetric hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2006 Jun; 29(6):674-8.
    View in: PubMed
  76. Shukla GJ, Zimetbaum PJ. Cardiology patient page. Syncope. Circulation. 2006 Apr 25; 113(16):e715-7.
    View in: PubMed
  77. Reynolds MR, Shah J, Essebag V, Olshansky B, Friedman PA, Hadjis T, Lemery R, Bahnson TD, Cannom DS, Josephson ME, Zimetbaum P. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 Feb 15; 97(4):538-43.
    View in: PubMed
  78. Essebag V, Baldessin F, Reynolds MR, McClennen S, Shah J, Kwaku KF, Zimetbaum P, Josephson ME. Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur Heart J. 2005 Dec; 26(23):2550-5.
    View in: PubMed
  79. Pickett CC, Zimetbaum PJ. Palpitations: a proper evaluation and approach to effective medical therapy. Curr Cardiol Rep. 2005 Sep; 7(5):362-7.
    View in: PubMed
  80. Zimetbaum PJ, Josephson ME. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005 Aug 11; 353(6):627-30; author reply 627-30.
    View in: PubMed
  81. Martinez EA, Bass EB, Zimetbaum P. Pharmacologic control of rhythm: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005 Aug; 128(2 Suppl):48S-55S.
    View in: PubMed
  82. Zimetbaum P. Is rate control or rhythm control preferable in patients with atrial fibrillation? An argument for maintenance of sinus rhythm in patients with atrial fibrillation. Circulation. 2005 Jun 14; 111(23):3150-6; discussion 3156-7.
    View in: PubMed
  83. Sorajja P, Gersh BJ, Costantini C, McLaughlin MG, Zimetbaum P, Cox DA, Garcia E, Tcheng JE, Mehran R, Lansky AJ, Kandzari DE, Grines CL, Stone GW. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J. 2005 Apr; 26(7):667-74.
    View in: PubMed
  84. Prasad A, Stone GW, Stuckey TD, Costantini CO, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Lansky AJ, Gersh BJ. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 2005 Feb 15; 45(4):508-14.
    View in: PubMed
  85. Coyne K, Margolis MK, Grandy S, Zimetbaum P. The state of patient-reported outcomes in atrial fibrillation : a review of current measures. Pharmacoeconomics. 2005; 23(7):687-708.
    View in: PubMed
  86. Zimetbaum P, Josephson ME. Is there a role for maintaining sinus rhythm in patients with atrial fibrillation? Ann Intern Med. 2004 Nov 2; 141(9):720-6.
    View in: PubMed
  87. McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004 Sep 15; 44(6):1215-23.
    View in: PubMed
  88. Zimetbaum PJ, Buxton AE, Batsford W, Fisher JD, Hafley GE, Lee KL, O'Toole MF, Page RL, Reynolds M, Josephson ME. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004 Aug 17; 110(7):766-9.
    View in: PubMed
  89. Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 2004 May 1; 93(9):1173-6.
    View in: PubMed
  90. Prasad A, Stone GW, Aymong E, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Gersh BJ. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J. 2004 Apr; 147(4):669-75.
    View in: PubMed
  91. Chen J, Anselme F, Smith TW, Zimetbaum P, Epstein LM, Papageorgiou P, Josephson ME. Standard right atrial ablation is effective for atrioventricular nodal reentry with earliest activation in the coronary sinus. J Cardiovasc Electrophysiol. 2004 Jan; 15(1):2-7.
    View in: PubMed
  92. Zimetbaum P, Reynolds MR, Ho KK, Gaziano T, McDonald MJ, McClennen S, Berezin R, Josephson ME, Cohen DJ. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003 Sep 15; 92(6):677-81.
    View in: PubMed
  93. McClennen S, Zimetbaum PJ. Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation. Curr Cardiol Rep. 2003 Sep; 5(5):380-6.
    View in: PubMed
  94. Tolat AV, Holper EM, Zimetbaum P. Anticoagulation management strategies in patients with atrial fibrillation. Crit Pathw Cardiol. 2003 Sep; 2(3):178-87.
    View in: PubMed
  95. Pinto DS, Ho KK, Zimetbaum PJ, Pedan A, Goldberger AL. Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rate. BMC Cardiovasc Disord. 2003 Aug 5; 3:7.
    View in: PubMed
  96. Hauser TH, Pinto DS, Josephson ME, Zimetbaum P. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2003 Jun 15; 91(12):1437-41.
    View in: PubMed
  97. Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May; 145(5):847-54.
    View in: PubMed
  98. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003 Mar 6; 348(10):933-40.
    View in: PubMed
  99. Zimetbaum P, Ho KK, Olshansky B, Hadjis T, Lemery R, Friedman PA, Cannom DS, Chen XH, Josephson ME. Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation. Am J Cardiol. 2003 Jan 1; 91(1):81-3.
    View in: PubMed
  100. Milliez P, Richardson AW, Obioha-Ngwu O, Zimetbaum PJ, Papageorgiou P, Josephson ME. Variable electrocardiographic characteristics of isthmus-dependent atrial flutter. J Am Coll Cardiol. 2002 Sep 18; 40(6):1125-32.
    View in: PubMed
  101. Manning WJ, Zimetbaum PJ. Direct current cardioversion of atrial fibrillation--the next 40 years. Mayo Clin Proc. 2002 Sep; 77(9):895-6.
    View in: PubMed
  102. Marine JE, Korley VJ, Obioha-Ngwu O, Chen J, Zimetbaum P, Papageorgiou P, Milliez P, Josephson ME. Different patterns of interatrial conduction in clockwise and counterclockwise atrial flutter. Circulation. 2001 Sep 4; 104(10):1153-7.
    View in: PubMed
  103. Zimetbaum P, Pinto D, Josephson ME. Inpatient or outpatient initiation of antiarrhythmic medications: why the controversy? Heart Dis. 2001 May-Jun; 3(3):148-51.
    View in: PubMed
  104. Zimetbaum PJ, Josephson ME, McDonald MJ, McClennen S, Korley V, Ho KK, Papageorgiou P, Cohen DJ. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J Am Coll Cardiol. 2000 Oct; 36(4):1223-7.
    View in: PubMed
  105. McClennen S, Zimetbaum PJ, Ho KK, Goldberger AL. Holter monitoring: are two days better than one? Am J Cardiol. 2000 Sep 1; 86(5):562-4, A9.
    View in: PubMed
  106. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med. 1999 May 18; 130(10):848-56.
    View in: PubMed
  107. Zimetbaum PJ, Schreckengost VE, Cohen DJ, Lemery R, Love D, Epstein LM, Laham R, Josephson ME. Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation. Am J Cardiol. 1999 Feb 1; 83(3):450-2, A9.
    View in: PubMed
  108. Zimetbaum PJ, Kim KY, Josephson ME, Goldberger AL, Cohen DJ. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. A cost-effectiveness analysis. Ann Intern Med. 1998 Jun 1; 128(11):890-5.
    View in: PubMed
  109. Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998 May 7; 338(19):1369-73.
    View in: PubMed
  110. Huang DT, Monahan KM, Zimetbaum P, Papageorgiou P, Epstein LM, Josephson ME. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1998 May; 9(5):462-9.
    View in: PubMed
  111. Zimetbaum PJ, Krishnan S, Gold A, Carrozza JP, Josephson ME. Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction. Am J Cardiol. 1998 Apr 1; 81(7):918-9.
    View in: PubMed
  112. Josephson ME, Zimetbaum P, Huang D, Sauberman R, Monahan KM, Callans DS. Pathophysiologic substrate for sustained ventricular tachycardia in coronary artery disease. Jpn Circ J. 1997 Jun; 61(6):459-66.
    View in: PubMed
  113. Zimetbaum P, Kim KY, Ho KK, Zebede J, Josephson ME, Goldberger AL. Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol. 1997 Feb 1; 79(3):371-2.
    View in: PubMed
  114. Josephson ME, Kirchhof C, el Shalakany A, Papageorgiou P, Zimetbaum P. Pathophysiologic substrate for ventricular tachycardia in coronary artery disease and non-ischemic heart disease. Isr J Med Sci. 1996 Oct; 32(10):875-9.
    View in: PubMed
  115. Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, Eder HA. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb. 1992 Apr; 12(4):416-23.
    View in: PubMed
  116. Frishman WH, Ooi WL, Derman MP, Eder HA, Gidez LI, Ben-Zeev D, Zimetbaum P, Heiman M, Aronson M. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol. 1992 Jan-Mar; 2(1-2):43-50.
    View in: PubMed
  117. Drood JM, Zimetbaum PJ, Frishman WH. Nicotinic acid for the treatment of hyperlipoproteinemia. J Clin Pharmacol. 1991 Jul; 31(7):641-50.
    View in: PubMed
  118. Zimetbaum P, Frishman W, Aronson M. Lipids, vascular disease, and dementia with advancing age. Epidemiologic considerations. Arch Intern Med. 1991 Feb; 151(2):240-4.
    View in: PubMed
  119. Zimetbaum P, Frishman WH, Kahn S. Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan; 31(1):25-37.
    View in: PubMed
  120. Zimetbaum P, Eder H, Frishman W. Probucol: pharmacology and clinical application. J Clin Pharmacol. 1990 Jan; 30(1):3-9.
    View in: PubMed
  121. Frishman WH, Zimetbaum P, Nadelmann J. Lovastatin and other HMG-CoA reductase inhibitors. J Clin Pharmacol. 1989 Nov; 29(11):975-82.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Zimetbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_